SearchDictionaryMobileLogin

Thomas A Buchholz Selected Research

Mastectomy (Mammectomy)

12/2007Effect of Postmastectomy Radiotherapy in Patients <35 Years Old With Stage II-III Breast Cancer Treated With Doxorubicin-Based Neoadjuvant Chemotherapy and Mastectomy.
12/2006African-American race is associated with a poorer overall survival rate for breast cancer patients treated with mastectomy and doxorubicin-based chemotherapy.
07/2006Fifteen-year results of a randomized prospective trial of hyperfractionated chest wall irradiation versus once-daily chest wall irradiation after chemotherapy and mastectomy for patients with locally advanced noninflammatory breast cancer.
12/2005Clinical investigation: regional nodal failure patterns in breast cancer patients treated with mastectomy without radiotherapy.
06/2005Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy.
12/2004Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy.
05/2004T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy.
09/2003Outcome of treatment for breast cancer patients with chest wall recurrence according to initial stage: implications for post-mastectomy radiation therapy.
10/2002Immediate breast reconstruction after skin-sparing mastectomy for the treatment of advanced breast cancer: radiation oncology considerations.
07/2002Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy.
01/2002Controversies regarding the use of radiation after mastectomy in breast cancer.

Articles by Research Topic

Disease

31Breast Neoplasms (Breast Cancer)
02/2008 - 01/2002
6Neoplasms (Cancer)
12/2007 - 07/2002
5Carcinoma (Carcinomatosis)
08/2005 - 06/2002
2Noninfiltrating Intraductal Carcinoma (DCIS)
03/2004 - 11/2002
1Ductal Carcinoma
10/2007
1Neoplasm Metastasis (Metastasis)
10/2005
1Death (Near-Death Experience)
03/2005
1Seminoma
12/2004
1Pneumonia (Pneumonitis)
11/2004

Drug/Important Bio-Agent (IBA)

6Doxorubicin (Adriamycin)FDA LinkGeneric
12/2007 - 10/2003
4Paclitaxel (Taxol)FDA LinkGeneric
01/2007 - 11/2004
3Epidermal Growth Factor Receptor (EGF Receptor)IBA
01/2007 - 06/2005
2Epirubicin (Ellence)FDA LinkGeneric
01/2007 - 06/2005
2trastuzumab (Herceptin)FDA Link
01/2007 - 06/2005
1Radio-Opaque (Boston Post)IBA
12/2007
1130-nm albumin-bound paclitaxelIBA
03/2007
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2007
1Fluorouracil (Carac)FDA LinkGeneric
01/2007
1Transcription Factors (Transcription Factor)IBA
12/2005
1polyphenolsIBA
11/2005
1tau Proteins (tau Protein)IBA
06/2005
1TamoxifenFDA LinkGeneric
03/2004
1Protein Kinases (Protein Kinase)IBA
02/2004
1NF-kappa B (NF-kB)IBA
11/2003
1Estrogens (Estrogen)FDA Link
07/2003
1RNA (Ribonucleic Acid)IBA
06/2003
1Cyclin EIBA
11/2002
1Biological Markers (Surrogate Marker)IBA
06/2002

Therapy/Procedure

24Drug Therapy (Chemotherapy)
02/2008 - 06/2002
11Mastectomy (Mammectomy)
12/2007 - 01/2002
3Neoadjuvant Therapy
01/2008 - 06/2005
2Segmental Mastectomy (Lumpectomy)
10/2007 - 11/2002
2Adjuvant Radiotherapy
10/2005 - 03/2005
1Aftercare (After-Treatment)
12/2004
1Mammaplasty (Breast Reconstruction)
10/2002
1Adjuvant Chemotherapy
07/2002